MedTrace Logo

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII

NCT02093845 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2017-04-25

No results posted yet for this study

Summary

The purpose of this study is to perform a randomised comparison between the SYNERGY and the Biomatrix NeoFlex stents in treatment of unselected patients with ischemic heart disease.

Conditions

Interventions

DEVICE

Biomatrix NeoFlex coronary stent

Percutaneous coronary intervention involving use of stent

DEVICE

SYNERGY stent

Percutaneous coronary intervention involving use of stent

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Biosensors Europe SA

    collaborator INDUSTRY

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Michael Maeng, MD · Aarhus University Hospital, Skejby, Aarhus N

  • Evald H Christiansen, MD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-10
Primary Completion
2015-08-24
Completion
2020-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02093845 on ClinicalTrials.gov